TOP2A and colorectal carcinoma: Altogether, these data strongly suggested that TOP2A played an essential role in the UPF1-induced chemoresistance of CRC cells in response to oxaliplatin in vitro and in vivo and TOP2A could be a therapeutic target in UPF1-overexpressed CRC patients.